Page:United States Statutes at Large Volume 114 Part 4.djvu/444

 114 STAT. 2506 PUBLIC LAW 106-525—NOV. 22, 2000 health disparity populations; J "(C) test such strategies and widely disseminate those strategies for which there is scientific evidence of effectiveness; and "(D) determine the most effective approaches for disseminating research findings to health disparity populations, including minority populations. "(2) USE OF CERTAIN STRATEGIES.— In carrying out this section, the Director shall implement research strategies and mechanisms that will enhance the involvement of individuals who are members of minority health disparity populations or other health disparity populations, health services researchers who are such individuals, institutions that train such individuals as researchers, members of minority health disparity populations or other health disparity populations for whom the Agency is attempting to improve the quality and outcomes of care, and representatives of appropriate tribal or other community-based organizations with respect to health disparity populations. Such research strategies and mechanisms may include the use of— "(A) centers of excellence that can demonstrate, either individually or through consortia, a combination of multidisciplinary expertise in outcomes or quality improvement research, linkages to relevant sites of care, and a demonstrated capacity to involve members and communities of health disparity populations, including minority health disparity populations, in the planning, conduct, dissemination, and translation of research; "(B) provider-based research networks, including health plans, facilities, or delivery system sites of care (especially primary care), that make extensive use of health care providers who are members of health disparity populations or who serve patients in such populations and have the capacity to evaluate and promote quality improvement; "(C) service delivery models (such as health centers under section 330 and the Indian Health Service) to reduce health disparities; and "(D) innovative mechanisms or strategies that will facilitate the translation of past research investments into clinical practices that can reasonably be expected to benefit these populations. " (c) QUALITY MEASUREMENT DEVELOPMENT. — "(1) IN GENERAL.—To ensure that health disparity populations, including minority health disparity populations, benefit from the progress made in the ability of individuals to measure the quality of health care delivery, the Director shall support the development of quality of health care measures that assess the experience of such populations with health care systems, such as measures that assess the access of such populations to health care, the cultural competence of the care provided, the quality of the care provided, the outcomes of care, or other aspects of health care practice that the Director determines to be important. " (2) EXAMINATION OF CERTAIN PRACTICES. —The Director shall examine the practices of providers that have a record of reducing health disparities or have experience in providing
 * to care for health disparity populations, including minority

�